PINI, Luigi Alberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.511
EU - Europa 9.044
AS - Asia 6.156
SA - Sud America 910
AF - Africa 85
Continente sconosciuto - Info sul continente non disponibili 19
OC - Oceania 11
Totale 32.736
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.354
GB - Regno Unito 3.382
IT - Italia 2.561
CN - Cina 2.345
SG - Singapore 1.836
HK - Hong Kong 819
BR - Brasile 724
SE - Svezia 705
DE - Germania 493
UA - Ucraina 479
VN - Vietnam 317
RU - Federazione Russa 285
FI - Finlandia 278
TR - Turchia 260
FR - Francia 217
KR - Corea 216
NL - Olanda 189
BG - Bulgaria 168
CA - Canada 104
ID - Indonesia 102
AR - Argentina 77
IE - Irlanda 72
IN - India 52
BE - Belgio 35
EC - Ecuador 34
MX - Messico 33
BD - Bangladesh 32
ES - Italia 32
ZA - Sudafrica 31
CH - Svizzera 27
JP - Giappone 25
AT - Austria 24
IR - Iran 24
CL - Cile 20
IQ - Iraq 19
PL - Polonia 19
CO - Colombia 16
BY - Bielorussia 15
PK - Pakistan 15
EU - Europa 13
MA - Marocco 13
LT - Lituania 12
VE - Venezuela 11
MY - Malesia 10
PE - Perù 10
AE - Emirati Arabi Uniti 9
NO - Norvegia 9
PY - Paraguay 9
TN - Tunisia 9
IL - Israele 8
PT - Portogallo 7
UZ - Uzbekistan 7
AU - Australia 6
DZ - Algeria 6
KZ - Kazakistan 6
NP - Nepal 6
RO - Romania 6
SA - Arabia Saudita 6
SN - Senegal 6
UY - Uruguay 6
YE - Yemen 6
CZ - Repubblica Ceca 5
PH - Filippine 5
AL - Albania 4
ET - Etiopia 4
JO - Giordania 4
KE - Kenya 4
AZ - Azerbaigian 3
BO - Bolivia 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
GE - Georgia 3
HU - Ungheria 3
KG - Kirghizistan 3
LB - Libano 3
RS - Serbia 3
TH - Thailandia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
BH - Bahrain 2
BW - Botswana 2
DK - Danimarca 2
EE - Estonia 2
EG - Egitto 2
GA - Gabon 2
GR - Grecia 2
HN - Honduras 2
JM - Giamaica 2
KW - Kuwait 2
LK - Sri Lanka 2
LV - Lettonia 2
LY - Libia 2
NZ - Nuova Zelanda 2
PA - Panama 2
PR - Porto Rico 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
A1 - Anonimo 1
Totale 32.718
Salva come PNG Salva come JPEG
Città #
Southend 2.672
Fairfield 1.719
Santa Clara 1.660
Woodbridge 1.392
Ashburn 1.342
Singapore 1.062
Jacksonville 1.005
Houston 956
Hefei 922
Hong Kong 811
Chandler 798
Dearborn 640
Wilmington 634
Seattle 592
Cambridge 573
Ann Arbor 561
Beijing 392
London 387
Nyköping 361
Chicago 263
Los Angeles 248
Milan 204
Seoul 202
Princeton 197
Modena 193
San Diego 175
Sofia 165
Eugene 162
Izmir 142
Rome 131
Buffalo 129
Helsinki 122
The Dalles 117
New York 115
Ho Chi Minh City 108
Moscow 105
Dallas 98
Council Bluffs 91
Salt Lake City 87
Jakarta 76
Redwood City 69
Shanghai 69
Dublin 67
Des Moines 64
Hanoi 64
São Paulo 57
Turin 54
Bologna 52
Naples 52
Columbus 37
Elk Grove Village 37
Nanjing 37
Tampa 37
Genoa 36
Brussels 33
Dong Ket 33
Ottawa 32
Rio de Janeiro 32
Brooklyn 31
San Jose 31
Verona 31
Bianco 29
Norwalk 29
Palermo 29
Phoenix 29
Bremen 28
Lancaster 27
Brescia 26
Falls Church 26
Boardman 25
Florence 25
Guangzhou 25
Munich 25
Orem 25
Atlanta 24
Toronto 23
Parma 22
Sterling 22
Tulare 21
Catania 20
Fremont 20
Jinan 20
Tokyo 20
Miami 18
Paris 18
Philadelphia 18
Perugia 17
Boston 16
Denver 16
Detroit 16
Redondo Beach 16
Warsaw 16
Bari 15
Johannesburg 15
Reggio Emilia 15
San Francisco 15
Venice 15
Chiswick 14
Como 14
Dongguan 14
Totale 23.372
Salva come PNG Salva come JPEG
Nome #
La flunarizina nella profilassi delel crisi emicraniche delle cefalee cclassiche e comuni 1.855
A double-blind, randomized, multicenter, Italian study of frovatriptan versus almotriptan for the acute treatment of migraine. 742
The antinociceptive effect of acetylsalicylic acid is differently affected by a CB1 agonist or antagonist and involves the serotonergic system in rats 381
OPPIACEI: FARMACOCINETICA, DIPENDENZA, DETOSSIFICAZIONE, TRATTAMENTI AGONISTI ED ANTAGONISTI 374
Differential involvement of opioidergic and serotoninergic systems in the antinociceptive activity of N-arachidonoyl-phenolamine (AM404) in the rat: comparison with paracetamol 325
A genome-wide analysis in cluster headache points to neprilysin and PACAP receptor gene variants 313
Serum protein changes in a rat model of chronic pain show a correlation between animal and humans 308
Proteomic analysis of urine in medication-overuse headache patients: possible relation with renal damages 299
Differential involvement of central 5-HT1B and 5-HT3 receptor subtypes in the antinociceptive effect of paracetamol 291
BRAIN-SEROTONIN BINDING-CAPACITY, ANALGESIA AND DRUG SERUM LEVELS AFTER ACUTE TREATMENT WITH PHENAZONE IN RATS 284
Effect of acute and repeated administration of paracetamol on opioidergic and serotonergic systems in rats. 284
Validation of potential candidate biomarkers of drug-induced nephrotoxicity and allodynia in medication-overuse headache 284
Endocannabinoids in chronic migraine: CSF findings suggest a system failure 283
Proteomic research of proteins involved in pain expression in an animal model of chronic pain 282
Basal cutaneous pain threshold in headache patients 273
A preliminary study on the relationship between central auditory processing and childhood primary headaches in the intercritical phase 269
Central antinociceptive activity of acetylsalicylic acid is modulated by brain serotonin receptor subtypes 268
NF-kappa B activity and iNOS expression in monocytes from internal jugular blood of migraine without aura patients during attacks 266
Discovery by a proteomic approach of possible early biomarkers of drug-induced nephrotoxicity in medication-overuse headache 266
Exploration of candidate serum biomarkers potentially related to the chronic pain condition in Medication-overuse headache 262
A case-control study of visually evoked postural responses in childhood with primary headaches 259
O015. Evaluation of the genetic polymorphism of the α3 (CHRNA3) and α5 (CHRNA5) nicotinic receptor subunits, in patients with cluster headache 253
Abnormalities in the cerebrospinal fluid levels of endocannabinoids in multiple sclerosis 250
Valutazione del contenuto plasmatico e possibile uso terapeutico del glutatione in pazienti con cefalea cronica quotidiana ed uso giornaliero di associazioni analgesiche 245
Anti-epileptic drugs in the preventive treatment of migraine headache : a brief review. 244
Nociceptin/orphanin FQ prevents the antinociceptive action of paracetamol on the rat hot plate test 241
A case of a GH-producing pituitary adenoma associated with a unilateral headache with autonomic signs 238
Headaches associated with chronic use of analgesics: A therapeutic approach 237
Diamo parole al dolore. La percezione del disagio e della difficoltà nella vita quotidiana delle bambine e dei bambini 234
PHYSIOLOGICAL-PARAMETERS AND PLASMA-LEVELS AFTER SHORT AND LONG-TERM PROPOFOL INFUSION 233
THE ROLE OF SEROTONIN BRAIN RECEPTORS IN THE ANALGESIC EFFECT OF PHENAZONE 233
Long-term follow-up of patients treated for chronic headache with analgesic overuse 232
PHARMACOKINETIC OF REDUCED GLUTATHIONE IN MAN - EFFECT ON PLASMA CYSTEINE AND THIOL COMPOUNDS 232
Italian guidelines for primary headaches: 2012 revised version. 232
Effect of rofecoxib on nociception and the serotonin system in the rat brain 231
A genetic association study of dopamine metabolism-related genes and chronic headache with drug abuse 229
Phenytoin-Treatment Of Rdeb Vegetans 228
Disposition of naproxen after oral administration during and between migraine attacks. 226
Acetylsalicyclic acid potentiates the antinociceptive effect of morphine in the rat:involvement of the central serotonergic system. 225
Effect of acetylsalicylic acid on formalin test and on serotonin system in the rat brain. 225
An unusual case report on the possible role of Warfarin in migraine prophylaxis 224
Lack of activity of Ketorolac in hot-plate test and serotonin binding capacity of brain membranes in rats 223
Genetic variation in CHRNA7 and CHRFAM7A is associated with nicotine dependence and response to varenicline treatment 223
Analgesic abuse in chronic headache sufferers 222
Effects of chronic treatment with phenazone on the hot plate test and [3H]-Serotonin binding sites in pons and cortex membranes of the rat 221
Serotonin and opiate involvement in the antinociceptive effect of acetylsalicylic acid 217
PHARMACOKINETICS OF TIAPROFENIC ACID AFTER ORAL-ADMINISTRATION IN FASTING PATIENTS DURING AND BETWEEN MIGRAINE ATTACKS 215
Risk-benefit and cost-benefit ratio in headache treatment 214
Nabilone for the treatment of medication overuse headache: results of a preliminary double-blind, active-controlled, randomized trial. 212
Plasma glutathione level in chronic headache drug abuser patients 211
Tolerability and efficacy of a combination of paracetamol and caffeine in the treatment of tension-type headache: a randomised, double-blind, double-dummy, cross-over study versus placebo and naproxen sodium 211
INTERNATIONAL-HEADACHE-SOCIETY CLASSIFICATION - INTEROBSERVER RELIABILITY IN THE DIAGNOSIS OF PRIMARY HEADACHES 210
Urine proteomic analysis in patients with cronic headache and overuse of analgesic drugs: possible relation with renal damage 207
Relevance of analgesic abuse in the maintenance of chronic headaches 204
INFLUENCE OF PROLONGED THERAPY WITH FLUNARIZINE ON GLUCOSE, INSULIN AND C-PEPTIDE METABOLISM 204
The effect of chronic treatment with phenazone on [3H]-serotonin binding sites in pons and cortex membranes of the rat 204
Different characteristics of triptans 202
The effect of paracetamol and morphine combination on dynorphin A levels in the rat brain. 202
Serum changes of apolipoproteins in Medication Overuse Headache (MOH) 202
The potentiation of analgesic activity of paracetamol plus morphine involves the serotonergic system in rat brain 201
Pharmacokinetics and tolerability of oral cannabis preparations in patients with medication overuse headache (MOH)—a pilot study 200
An emerging problem in clinical practice: how to treat chronic headache patients. 199
Homocysteine levels and cardiovascular disease in migraine with aura 199
Migraine preventive drug-induced weight gain may be mediated by effects on hypothalamic peptides: the results of a pilot study. 199
HIGH EFFICACY AND LOW-FREQUENCY OF HEADACHE RECURRENCE AFTER ORAL SUMATRIPTAN 197
Pharmacological outline of chronic headache patients: overlap between depressive and nociceptive symptomatology 197
Plasma reduced glutathione level and changes in thiol groups after glutathione administration in drug abuser patients - 196
Triptans: the experience of a clinical pharmacologist in clinical practice. 196
Lack of association between five serotonin metabolism-relatedgenes and medication overuse headache. 195
Chronic daily headache: how to manage it? 193
Involvement of brain serotonergic system in the antinociceptive action of acetylsalicylic acid in the rat 192
Preclinical pharmacological profile of the selective 5-HT1F receptor agonist lasmiditan. A comment. 192
The antinociceptive action of paracetamol is associated with changes in the serotonergic system in the rat brain 191
Analysis on the use of migraine preventative drugs in current clinical practice 189
CHRNA5 polymorphism and nicotine dependence in patients with cluster headache 189
DOES CHRONIC USE OF SUMATRIPTAN INDUCE DEPENDENCE 189
Tacrolimus pharmacokinetics in kidney transplant recipients. 188
Nimodipine in otolaryngology: from past evidence to clinical perspectives 188
Frovatriptan versus almotriptan for acute treatment of menstrual migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study 187
Endocannabinoids in platelets of chronic migraine patients and medication-overuse headache patients: relation with serotonin levels 187
Comparison of tolerability and efficacy of a combination of paracetamol + caffeine and sumatriptan in the treatment of migraine attack: a randomized, double-blind, double-dummy, cross-over study. 185
Evaluation of a possible relationship between medication-overuse headache and potential renal dysfunctions by a proteomic study on urine samples 184
Sodium valproate in migraine without aura and medication overuse headache: a randomized controlled trial 182
Impact of continuing or quitting smoking on episodic cluster headache: a pilot survey 182
Clinical-biochemical correlates of migraine attacks in rizatriptan responders and non-responders 181
Topo-kinesthetic memory in chronic headaches. A new test for chronic patients: preliminary report 181
Switching from HPLC/UV to MEIA for whole blood sirolimus quantitation: Comparison of methods 180
Pharmacokinetics of tia profenic acid in headache attacks - a preliminary report 178
PHARMACOKINETICS OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS 178
Active reporting scheme: an example to evaluate specific adverse drug reactions. 178
The effect of Paracetamol on nociception and dynorphin A levels in the rat brain 178
High prevalence of patent foramen ovale in migraine with aura 178
Circadian variations of proopiocortin-related peptides in children with migraine. 175
Urinary neopterin in malignant lymphoma 175
The genetics of chronic headaches. 174
Ambiti e limiti delle prescrizioni farmaceutiche nell'esercizio dell'odontoiatria e protesi dentaria 173
Chronic treatment with naltrexone and hepatic functions in heroin addicts 173
PHARMACOKINETICS OF NAPROXEN AFTER ORAL-ADMINISTRATION DURING AND OUT OF MIGRAINE ATTACKS 171
Psycological profiles in tobacco and drug abusers 170
Serotonergic and opiatergic modifications induced by paracetamol as a model for daily chronic headache with analgesic overuse 169
Totale 24.273
Salva come PNG Salva come JPEG
Categoria #
all - tutte 123.155
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 123.155
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.910 0 0 0 0 0 224 306 444 110 468 190 168
2021/20222.935 92 450 319 326 66 75 194 139 279 198 443 354
2022/20232.399 308 231 141 208 268 363 49 213 300 51 120 147
2023/20242.231 116 143 158 171 370 166 200 268 93 83 223 240
2024/20256.336 282 117 155 473 1.230 883 341 311 840 467 595 642
2025/20265.880 716 540 1.207 1.289 1.331 797 0 0 0 0 0 0
Totale 32.842